The Southeast Alaska Regional Health Consortium and the Yale School of Medicine have started a $2.6 million study on the drug naltrexone and how it may be effective in treating Alaska Natives suffering from alcoholism.
Sign up for The Signal
Top Alaska stories delivered to your inbox every week
Leave a Reply
You must be logged in to post a comment.